In the short term, the next catalyst is getting current and hopefully settling with the SEC.
Per Rik‘s email, by the end of summer we will know if we’re going to get a government grant or not
The joint venture is still in place, and per Rik’s email it’s no longer or maybe never was contingent on the outcome of the SEC situation, and they are planning to start clinical trials by the end of the year.
Obviously a government grant is the big one, but if that doesn’t happen starting fully funded clinical trials is a big deal as well